Beam Therapeutics Inc.

09/27/2021 | Press release | Distributed by Public on 09/27/2021 04:42

Beam Therapeutics Announces Preclinical Data Highlighting Potential of Base Editors to Target Disease Drivers of Chronic Hepatitis B Infection